Abstract
Quantitative structure activity relationship approach using enhanced replacement method for variable selection was applied to a series of imidazole containing tetrahydrobenzodiazepines as inhibitors of farnesyltransferase. For the purpose the dataset was divided into training set of 31 compounds and test set of 5 compounds using k means clustering. Statistically significant equations were obtained with high correlation coefficient coefficient (R=0.9637) and low standard deviation (S=0.3715). The robustness of the model was confirmed with the help of R2cv with a value of 0.8886, Y scrambling and by predicting the activities of test compounds. A good correlation of KierA3 shape indices and polarizability with the farnesyltransferase inhibitory activity was achieved.
Keywords: QSAR, Farnesyltransferase Inhibitors, Tetrahydrobenzodiazepines, Y scrambling, Polarizability, Imidazole, Ras proteins, PFT inhibitors, metalloenzyme, GABAA, Kubinyi function (FIT), apol, Specific Polarizability, Spol(R4)
Letters in Drug Design & Discovery
Title: Exploring the Structure Activity Relationships of Imidazole Containing Tetrahydrobenzodiazepines as Farnesyltransferase Inhibitors: A QSAR Study
Volume: 8 Issue: 6
Author(s): Anand Gaurav, Vertika Gautam and Ranjit Singh
Affiliation:
Keywords: QSAR, Farnesyltransferase Inhibitors, Tetrahydrobenzodiazepines, Y scrambling, Polarizability, Imidazole, Ras proteins, PFT inhibitors, metalloenzyme, GABAA, Kubinyi function (FIT), apol, Specific Polarizability, Spol(R4)
Abstract: Quantitative structure activity relationship approach using enhanced replacement method for variable selection was applied to a series of imidazole containing tetrahydrobenzodiazepines as inhibitors of farnesyltransferase. For the purpose the dataset was divided into training set of 31 compounds and test set of 5 compounds using k means clustering. Statistically significant equations were obtained with high correlation coefficient coefficient (R=0.9637) and low standard deviation (S=0.3715). The robustness of the model was confirmed with the help of R2cv with a value of 0.8886, Y scrambling and by predicting the activities of test compounds. A good correlation of KierA3 shape indices and polarizability with the farnesyltransferase inhibitory activity was achieved.
Export Options
About this article
Cite this article as:
Gaurav Anand, Gautam Vertika and Singh Ranjit, Exploring the Structure Activity Relationships of Imidazole Containing Tetrahydrobenzodiazepines as Farnesyltransferase Inhibitors: A QSAR Study, Letters in Drug Design & Discovery 2011; 8 (6) . https://dx.doi.org/10.2174/157018011795906758
DOI https://dx.doi.org/10.2174/157018011795906758 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Evaluation of Drug Transporter Interactions in Drug Discovery and Development
Combinatorial Chemistry & High Throughput Screening The Toolbox of Designing Nanoparticles for Tumors
Mini-Reviews in Medicinal Chemistry Selectively Targeted Anti-Neoplastic Cytotoxicity of Three Immunopharmaceuticals with Covalently Bound Fludarabine, Gemcitabine and Dexamethasone Moieties Synthesized Utilizing Organic Chemistry Reactions in a Multi-Stage Regimen
Current Pharmaceutical Design The Role of Phospholipase D Enzyme(s) in Modulating Cell Signaling: Implications for Cancer Drug Development
Current Bioactive Compounds On the Use of Hydrogels in Cell Encapsulation and Tissue Engineering Systems
Recent Patents on Drug Delivery & Formulation Potential Application of Induced Pluripotent Stem Cells in Cell Replacement Therapy for Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Glycerophospholipid Synthesis as a Novel Drug Target Against Cancer
Current Molecular Pharmacology Immune Responses to Adeno-Associated Virus Vectors
Current Gene Therapy Drug Discovery Using Yeast as a Model System: A Functional Genomic and Proteomic View
Current Proteomics Thyroid Ultrasound and Other Imaging Procedures in the Pediatric Age
Current Pediatric Reviews High Throughput Screening for Colorectal Cancer Specific Compounds
Combinatorial Chemistry & High Throughput Screening Plant Polyphenols and Tumors: From Mechanisms to Therapies, Prevention, and Protection Against Toxicity of Anti-Cancer Treatments
Current Medicinal Chemistry A Glimpse of Matrix Metalloproteinases in Diabetic Nephropathy
Current Medicinal Chemistry Inflammation and Cancer: In Medio Stat Nano
Current Medicinal Chemistry Editorial [Personalized Vaccines and Public Health Genomics: Anticipating and Monitoring the ELSIs]
Current Pharmacogenomics and Personalized Medicine Structural Elucidation of Unique Inhibitory Activities of Two Thiazolo[ 4,5-d]pyrimidines Against Epidermal Growth Factor Receptor (EGFR): Implications for Successful Drug Design
Medicinal Chemistry TGF-beta Signaling in Cancer Treatment
Current Pharmaceutical Design Overview
Anti-Cancer Agents in Medicinal Chemistry Toxicological Effects of Dietary Biogenic Amines
Current Nutrition & Food Science Atherosclerosis Neovascularization and Imaging
Current Molecular Medicine